about
Novel epigenetic target therapy for prostate cancer: a preclinical studypRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancerNewly engineered magnetic erythrocytes for sustained and targeted delivery of anti-cancer therapeutic compoundsSeparate and combined effects of DNMT and HDAC inhibitors in treating human multi-drug resistant osteosarcoma HosDXR150 cell lineSearching for the perfect wave: the effect of radiofrequency electromagnetic fields on cells.Immunoglobulin gene rearrangement analysis in composite hodgkin disease and large B-cell lymphoma: evidence for receptor revision of immunoglobulin heavy chain variable region genes in Hodgkin-Reed-Sternberg cells?Different approaches to the study of apoptosis.Pathway landscapes and epigenetic regulation in breast cancer and melanoma cell lines.Targeting Cancer with Epi-Drugs: A Precision Medicine Perspective.Localization of single copy gene by PRINS technique.How does a normal human cell become a cancer cell?Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes.Detection of apoptotic deoxyribonucleic acid break by in situ nick translation.Single and double colloidal gold labeling in postembedding immunoelectron microscopy.Multifluorescence labeling and colocalization analyses.Modulation of cell cycle components by epigenetic and genetic events.Multiple genetic and epigenetic interacting mechanisms contribute to clonally selection of drug-resistant tumors: current views and new therapeutic prospective.Time-course gene profiling and networks in demethylated retinoblastoma cell line.Nuclear matrix involvement in sperm head structural organization.Immunomediated Pan-cancer Regulation Networks are Dominant Fingerprints After Treatment of Cell Lines with Demethylation.Enhanced resolution of specific chromosome and nuclear regions by reflectance laser scanning confocal microscopy.FAT1: a potential target for monoclonal antibody therapy in colon cancer.Ensemble inference by integrative cancer networks.Expression of RB2/p130 tumor-suppressor gene in AIDS-related non-Hodgkin's lymphomas: implications for disease pathogenesis.Magnetically driven nanoparticles: 18 FDG-radiolabelling and positron emission tomography biodistribution study.Mutations in the retinoblastoma-related gene RB2/p130 in primary nasopharyngeal carcinoma.Microwave electromagnetic field regulates gene expression in T-lymphoblastoid leukemia CCRF-CEM cell line exposed to 900 MHz.Genetic and epigenetic alterations of RB2/p130 tumor suppressor gene in human sporadic retinoblastoma: implications for pathogenesis and therapeutic approach.Interaction between HIV-1 Tat and pRb2/p130: a possible mechanism in the pathogenesis of AIDS-related neoplasms.Triggering of p73-dependent apoptosis in osteosarcoma is under the control of E2Fs-pRb2/p130 complexes.Missing expression of pRb2/p130 in human retinoblastomas is associated with reduced apoptosis and lesser differentiation.A serine 37 mutation associated with two missense mutations at highly conserved regions of p53 affect pro-apoptotic genes expression in a T-lymphoblastoid drug resistant cell line.Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer.Nuclear matrix-bound replicational sites detected in situ by 5-bromodeoxyuridine.Multitype Network-Guided Target Controllability in Phenotypically Characterized Osteosarcoma: Role of Tumor Microenvironment.Sequence-tagged sites (STSs) from YAC insert-ends and X-specific flow-sorted chromosomes.Genetic alterations at the nuclear localization signal of the RB2/p130 gene occur in lymphoid tumor but not in osteosarcoma cell lines.Application of the primer in situ DNA synthesis (PRINS) technique to titer recombinant virus and evaluation of the efficiency of viral transduction.Innovative erythrocyte-based carriers for gene delivery in porcine vascular smooth muscle cells: basis for local therapy to prevent restenosis.Exposure to 900 MHz electromagnetic field induces an unbalance between pro-apoptotic and pro-survival signals in T-lymphoblastoid leukemia CCRF-CEM cells.
P50
Q27330048-75CBDD9E-A0C9-4B6F-80C5-9867934005E9Q28177191-5AC0D08F-A09A-4B99-976C-9121D16BB073Q28477252-71D2B4BB-5581-483E-BD50-C2AEAC8D68ACQ28538117-CDF47155-97ED-437C-8704-3080992B2FF8Q30438743-78CC3449-2154-4042-9905-471EABB4828CQ30815651-355C1C96-D41F-46CF-AC9D-0D488CDA7D32Q31976160-712F3EA7-53A3-46A5-83E7-E6310B567F5FQ33941999-6C38F448-C46A-4D7C-BC26-69A90C14C9D5Q34528462-36B6483F-A47A-4207-9946-F5C616B2AAECQ35018225-AECD2382-F140-415F-ACBD-E7CEE8A58CCBQ35724905-D8D5D137-47DB-4F47-BDA1-34C7B076EF30Q35809785-B5AD05F1-3386-4925-BF2D-5CE518224E6FQ35843020-3645BC64-3F6E-4286-85BF-F7168C77E017Q35843043-20C3272F-FA8D-4A66-9130-B3B4B90D3B47Q35843048-40BDC9E2-0550-4A04-8C18-FA360F3BD506Q36279315-0AC29CC6-C8DF-470A-80C3-8B40CCC07198Q36297321-7DE880B1-61A3-434F-957B-107CD2BDF5B6Q36414265-3A831C10-4031-451D-9007-6A6E956E1962Q36729568-4C281E36-EDBB-4420-B53C-0B5C28B264BCQ36848243-FCA651BA-48C5-4149-95E8-DD32BE726815Q36849779-3DA6CFE7-040F-40C9-98DB-FCC81A672FBBQ37061340-E78D6947-1ECC-4EC4-AF9A-796C2223EB37Q37689484-8054C4BC-DCC6-478F-AB3D-8323CDC8ADD5Q38363528-A767445D-2294-4787-AC96-28A9D760CB29Q38774869-9789DA59-1991-4F4C-952F-C9BAA4CE94F2Q38948332-B94C8FCD-2427-4BC4-91C1-EEC57DC53217Q39396807-9DA92DB4-4569-4434-90FB-BE9C15C34135Q40399331-BD682076-DC66-4AF8-B935-A7ADE5294636Q40633701-3AD2C4C1-6DA5-4EFF-9509-5F4480FA8D05Q40642091-D2A97B2B-A966-466B-88F4-EC02B655DD20Q40687346-6A35709A-1733-4DB1-BC1D-4DAAD8C19D88Q40847256-108E1B10-4C49-4A00-AF63-DF53E0938A2FQ40900966-F4CE7712-D23F-4670-B11D-C4BB75D8C74DQ41099884-BFB93E20-9151-4DF4-A8ED-DFEC4596A63CQ41183987-6B862EE3-7ED9-4855-AFC8-058477F43301Q41452052-076BEFD0-B7BE-44A4-9636-7728B3FA396EQ43625177-1F63E807-6076-44E1-9092-0D2E65F54AA1Q45738139-6DC4D214-A866-4D46-8B7A-7531872332E2Q46613869-0DD71E24-550A-4B00-AB21-2B3EF8C28455Q48151899-4E3E499F-4EB7-439C-BAC2-5C18A9D9F185
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Caterina Cinti
@ast
Caterina Cinti
@en
Caterina Cinti
@es
Caterina Cinti
@nl
Caterina Cinti
@sl
type
label
Caterina Cinti
@ast
Caterina Cinti
@en
Caterina Cinti
@es
Caterina Cinti
@nl
Caterina Cinti
@sl
prefLabel
Caterina Cinti
@ast
Caterina Cinti
@en
Caterina Cinti
@es
Caterina Cinti
@nl
Caterina Cinti
@sl
P106
P21
P31
P496
0000-0001-8049-0369